Anti-DLL4 antibody
4
(1 Review)
|
(0 Publication)
Rabbit Polyclonal DLL4 antibody. Suitable for WB and reacts with Xenopus laevis samples.
View Alternative Names
UNQ1895/PRO4341, DLL4, Delta-like protein 4, Drosophila Delta homolog 4, Delta4
- WB
Lab
Western blot - Anti-DLL4 antibody (AB223029)
All lanes:
Anti-DLL4 antibody (ab223029) at 1 µg/mL
Lane 1:
Xenopus laevis stage 12 at 20 µg
Lane 2:
Xenopus laevis stage 28 at 20 µg
Lane 3:
Xenopus laevis stage 31 at 20 µg
Lane 4:
Xenopus laevis stage 34 at 20 µg
Lane 5:
Xenopus laevis stage 37 at 20 µg
Lane 6:
Xenopus laevis stage 39 at 20 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 74 kDa
Observed band size: 76 kDa
true
Exposure time: 20min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DLL4 engages in precise regulation of angiogenesis and vascular development. It participates in the Notch signaling pathway playing an integral role in controlling endothelial cell proliferation differentiation and migration. DLL4 does not operate in isolation; instead it functions as part of the Notch receptor-ligand complex. This relationship effectively regulates the sprouting of new blood vessels ensuring proper vascular patterning and functional blood supply.
Pathways
DLL4 links directly to the Notch signaling and VEGF (vascular endothelial growth factor) pathways both of which play critical roles in vascular development and homeostasis. Through the Notch pathway DLL4 interacts with Notch1 and Notch4 receptors facilitating communication that inhibits endothelial cell proliferation distinguishing it from other pro-angiogenic factors. Its relationship with the VEGF pathway allows DLL4 to modulate angiogenic processes balancing vessel sprouting by opposing excessive VEGF-induced activities.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com